Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Zumilokibart in Dermatitis, Atopic: NCT07027527 Clinical Landscape Report 2026
16 October 2026
NCT07027527 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
OPB-101 in Recurrent ovarian cancer: NCT07030907 Clinical Landscape Report 2026
16 October 2026
NCT07030907 clinical landscape for Recurrent ovarian cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
HS-20118 in Psoriasis: NCT07033234 Clinical Landscape Report 2026
16 October 2026
NCT07033234 clinical landscape for Psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Apatinib Mesylate in HRD-positive Ovarian Cancer: NCT07033819 Clinical Landscape Report 2026
16 October 2026
NCT07033819 clinical landscape for HRD-positive Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Olevaprubart in Eczema: NCT07037901 Clinical Landscape Report 2026
16 October 2026
NCT07037901 clinical landscape for Eczema: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Recombinant anti-IL-4Rα humanized monoclonal antibody (Sunshine Guojian) in Dermatitis, Atopic: NCT07042126 Clinical Landscape Report 2026
16 October 2026
NCT07042126 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Recombinant anti-IL-4Rα humanized monoclonal antibody (Sunshine Guojian) in Dermatitis, Atopic: NCT07042113 Clinical Landscape Report 2026
16 October 2026
NCT07042113 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cyclosporine in Psoriasis vulgaris: CTRI/2025/07/090140 Clinical Landscape Report 2026
16 October 2026
CTRI/2025/07/090140 clinical landscape for Psoriasis vulgaris: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Utidelone in Primary peritoneal carcinoma: NCT07044349 Clinical Landscape Report 2026
16 October 2026
NCT07044349 clinical landscape for Primary peritoneal carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Paclitaxel in Platinum-Resistant Ovarian Carcinoma: NCT07042802 Clinical Landscape Report 2026
16 October 2026
NCT07042802 clinical landscape for Platinum-Resistant Ovarian Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
SHR-1139 in Plaque psoriasis: NCT07051538 Clinical Landscape Report 2026
16 October 2026
NCT07051538 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Trastuzumab Rezetecan in Recurrent Cervical Cancer: NCT07051486 Clinical Landscape Report 2026
16 October 2026
NCT07051486 clinical landscape for Recurrent Cervical Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.